ARTICLE | Company News
Apexigen Inc., 3SBio deal
June 29, 2015 7:00 AM UTC
Apexigen granted 3SBio rights outside of China to SSS07. 3SBio already held rights in China to the humanized mAb that inhibits tumor necrosis factor (TNF) alpha under a 2006 deal. The companies decl...